Gastric Pathophysiology in Diabetes

Sponsor
Institute for Clinical and Experimental Medicine
Study ID
NCT06068114
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Accepted

Study Details

This is a comprehensive pathophysiological study assessing various gastric functions in patients with diabetes mellitus. The investigators aim to examine the stomach with various measurement devices to gain information about its different functions and malfunctions. After the initial measurements, the examinations will be repeated after a year in each patient. Changes in the measurement values will be examined and their relations to each other and to the overall health of the patients will be investigated. For example it is hypothesised that diabetic patients also suffering from functional dyspepsia or gastroparesis will also show some changes in the function of the pyloric muscle.

Key Dates

First listed
Oct 5, 2023
Start date
Oct 5, 2022
Status verified
May 2024
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
120 participants (estimated)

Arms

  • Arm: Diabetic patients
    Either type I or type II diabetes mellitus, possibly also suffering from functional dyspepsia or gastroparesis
  • Arm: Healthy controls

Primary Outcome Measure

Pyloric distensibility [ Time Frame: At baseline and after 12 months ]

Central Contacts

Find similar trials

Nationwide
Type 1 diabetes trialsType 2 diabetes trialsEndocrinology trialsMetabolic health trialsWeight loss trials

Related Studies